Skip to main content
Erschienen in: International Ophthalmology 2/2021

14.10.2020 | Original Paper

Evaluation of the outcome of long-tube shunt implant surgery in uveitic glaucoma patients by analyzing the background of uveitis

verfasst von: Satoshi Watanabe, Teruhiko Hamanaka, Tetsuro Sakurai, Kanae Kobayashi, Nobuo Ishida, Nobuyuki Ebihara

Erschienen in: International Ophthalmology | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the efficacy of long-tube shunt surgery (LTSS) without valve in uveitic glaucoma (UG) eyes.

Methods

We retrospectively analyzed the data of 45 UG eyes that underwent only LTSS or LTSS combined with trabeculectomy (TLE) (LTSS/TLE). The UG eyes were analyzed by categorizing them into granulomatous/non-granulomatous, steroid responder/non-responder, and primary open-angle glaucoma (POAG) (POAG background)/non-POAG (non-POAG background). All granulomatous UG eyes received a continuous 3-times-daily administration of topical betamethasone post-LTSS.

Results

The eyes consisted of granulomatous (37 eyes, 82%)/non-granulomatous (5 eyes, 11%), steroid responder (19 eyes, 42%)/non-steroid responder (13 eyes, 29%), and 20 eyes with POAG or POAG background (p = 0.0022, 83%) among 24 cases of unilateral UG. The 5-year survival rates of only LTSS and LTSS/TLE were 66% and 100%, respectively. Kaplan–Meier survival-curve estimates in the non-granulomatous group were 100% for 6-year postoperative period, while the granulomatous group showed a gradual decrease along the 6-year (81%) postoperative period. The 5-year survival rates in the steroid responder group and the non-steroid responder group eyes were 74% and 78%, respectively. No intraocular pressure (IOP) elevation was observed in the positive steroid responder eyes post-LTSS.

Conclusions

LTSS and LTSS/TLE were both effective in UG. Positive steroid response may be masked by LTSS in the positive responder eyes. Continuous administration of topical betamethasone post-LTSS may be important for preventing an IOP spike by suppressing inflammation in the anterior chamber. LTSS combined with TLE may be recommended in eyes with granulomatous UG, and the coexistence of a POAG/POAG background.
Literatur
1.
Zurück zum Zitat Jampel HD, Jabs DA, Quigley HA (1990) Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma. Am J Ophthalmol 109:168–173CrossRef Jampel HD, Jabs DA, Quigley HA (1990) Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma. Am J Ophthalmol 109:168–173CrossRef
2.
Zurück zum Zitat Towler HM, McCluskey P, Shaer B, Lightman S (2000) Long-term follow up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucoma. Ophthalmology 107:1822–1828CrossRef Towler HM, McCluskey P, Shaer B, Lightman S (2000) Long-term follow up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucoma. Ophthalmology 107:1822–1828CrossRef
3.
Zurück zum Zitat Ceballos EM, Beck AD, Lynn MJ (2002) Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma 11(3):189–196CrossRef Ceballos EM, Beck AD, Lynn MJ (2002) Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma 11(3):189–196CrossRef
4.
Zurück zum Zitat Noble J, Derzko-Dzulynsky L, Rabinovitch T, Birt C (2007) Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma. Can J Ophthalmol 42:89–94CrossRef Noble J, Derzko-Dzulynsky L, Rabinovitch T, Birt C (2007) Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma. Can J Ophthalmol 42:89–94CrossRef
5.
Zurück zum Zitat Kaburaki T, Koshino T, Kawashima H, Numaga J, Tomidokoro A, Shirato S, Araei M (2009) Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. Eye 23:1509–1517CrossRef Kaburaki T, Koshino T, Kawashima H, Numaga J, Tomidokoro A, Shirato S, Araei M (2009) Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. Eye 23:1509–1517CrossRef
6.
Zurück zum Zitat Chawla A, Mercieca K, Fenerty C, Jones NP (2013) Outcomes and complications of trabeculectomy enhanced with 5-fluorouracil in adults with glaucoma secondary to uveitis. J Glaucoma 22:663–666CrossRef Chawla A, Mercieca K, Fenerty C, Jones NP (2013) Outcomes and complications of trabeculectomy enhanced with 5-fluorouracil in adults with glaucoma secondary to uveitis. J Glaucoma 22:663–666CrossRef
7.
Zurück zum Zitat Iwao k, Inatani M, Seto T, Takihara Y, Ogata-Iwao M, Okinami S, Tanihara H, (2014) Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma: a retrospective cohort study. J Glaucoma 23:88–94CrossRef Iwao k, Inatani M, Seto T, Takihara Y, Ogata-Iwao M, Okinami S, Tanihara H, (2014) Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma: a retrospective cohort study. J Glaucoma 23:88–94CrossRef
8.
Zurück zum Zitat Iverson SM, Bhardwaj N, Shi W, Sehi M, Greenfield DS, Budenz DL, Kishor K (2015) Surgical outcomes of inflammatory glaucoma: a comparison of trabeculectomy and glaucoma-drainage-device implantation. Jpn J Ophthalmol 59:179–186CrossRef Iverson SM, Bhardwaj N, Shi W, Sehi M, Greenfield DS, Budenz DL, Kishor K (2015) Surgical outcomes of inflammatory glaucoma: a comparison of trabeculectomy and glaucoma-drainage-device implantation. Jpn J Ophthalmol 59:179–186CrossRef
9.
Zurück zum Zitat Baudouin C, Pisella PJ, Fillacier K, Goldschild M, Becquet F, De Saint JM, Béchetoille A (1999) Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 106:556–563CrossRef Baudouin C, Pisella PJ, Fillacier K, Goldschild M, Becquet F, De Saint JM, Béchetoille A (1999) Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology 106:556–563CrossRef
10.
Zurück zum Zitat Ophir A, Ticho U (1992) Delayed filtering bleb encapsulation. Ophthalmic Surg 23:38–39PubMed Ophir A, Ticho U (1992) Delayed filtering bleb encapsulation. Ophthalmic Surg 23:38–39PubMed
11.
Zurück zum Zitat Skuta GL, Parrish RK 2nd (1987) Wound healing in glaucoma filtering surgery. Surv Ophthalmol 32:149–170CrossRef Skuta GL, Parrish RK 2nd (1987) Wound healing in glaucoma filtering surgery. Surv Ophthalmol 32:149–170CrossRef
12.
Zurück zum Zitat Shimizu A, Maruyama K, Yokoyama Y, Tsuda S, Ryu M, Nakazawa T (2014) Characteristics of uveitic glaucoma and evaluation of its surgical treatment. Clin Ophthalmol 26:2383–2389CrossRef Shimizu A, Maruyama K, Yokoyama Y, Tsuda S, Ryu M, Nakazawa T (2014) Characteristics of uveitic glaucoma and evaluation of its surgical treatment. Clin Ophthalmol 26:2383–2389CrossRef
13.
Zurück zum Zitat Ceballos EM, Parrish RK 2nd, Schiffman JC (2002) Outcome of Baerveldt glaucoma drainage implants for treatment of uveitic glaucoma. Ophthalmology 109:2256–2260CrossRef Ceballos EM, Parrish RK 2nd, Schiffman JC (2002) Outcome of Baerveldt glaucoma drainage implants for treatment of uveitic glaucoma. Ophthalmology 109:2256–2260CrossRef
14.
Zurück zum Zitat Tan AN, Cornelissen MF, Webers CAB, Erckens RJ, Berendschot TTJM, Beckers HJM (2018) Outcomes of severe uveitic glaucoma treated with Baerveldt implant: can blindness be prevented? Acta Ophthalmol 96:24–30CrossRef Tan AN, Cornelissen MF, Webers CAB, Erckens RJ, Berendschot TTJM, Beckers HJM (2018) Outcomes of severe uveitic glaucoma treated with Baerveldt implant: can blindness be prevented? Acta Ophthalmol 96:24–30CrossRef
15.
Zurück zum Zitat Da Mata A, Burk SE, Netland PA, Baltatzis CW, Foster CS (1999) Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology 106:2168–2172CrossRef Da Mata A, Burk SE, Netland PA, Baltatzis CW, Foster CS (1999) Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology 106:2168–2172CrossRef
16.
Zurück zum Zitat Ozdal PC, Vianna RN, Deschenes J (2006) Ahmed valve implantation in glaucoma secondary to chronic uveitis. Eye 20:178–183CrossRef Ozdal PC, Vianna RN, Deschenes J (2006) Ahmed valve implantation in glaucoma secondary to chronic uveitis. Eye 20:178–183CrossRef
17.
Zurück zum Zitat Gil-Carrasco F, Salinas-VanOrman E, Recillas-Gispert C, Paczka JA, Gilbert ME, Arellanes-Garcia L (1998) Ahmed valve implant for uncontrolled uveitic glaucoma. Ocul Immunol Inflamm 6:27–37CrossRef Gil-Carrasco F, Salinas-VanOrman E, Recillas-Gispert C, Paczka JA, Gilbert ME, Arellanes-Garcia L (1998) Ahmed valve implant for uncontrolled uveitic glaucoma. Ocul Immunol Inflamm 6:27–37CrossRef
18.
Zurück zum Zitat Molteno AC, Sayawat N, Herbison P (2001) Otago glaucoma surgery outcome study: long-term results of uveitis with secondary glaucoma drained by Molteno implants. Ophthalmology 108:605–613CrossRef Molteno AC, Sayawat N, Herbison P (2001) Otago glaucoma surgery outcome study: long-term results of uveitis with secondary glaucoma drained by Molteno implants. Ophthalmology 108:605–613CrossRef
19.
Zurück zum Zitat Chhabra R, Tan SZT, Au L, Spencer AF, Fenerty CH, Jones NP (2018) Long-term outcomes and complications of Baerveldt glaucoma drainage implants in adults with glaucoma secondary to uveitis. Ocul Immunol Inflamm 13:1–8 Chhabra R, Tan SZT, Au L, Spencer AF, Fenerty CH, Jones NP (2018) Long-term outcomes and complications of Baerveldt glaucoma drainage implants in adults with glaucoma secondary to uveitis. Ocul Immunol Inflamm 13:1–8
20.
Zurück zum Zitat Rachmiel R, Trope GE, Buys YM, Flanagan JG, Chipman ML (2008) Ahmed glaucoma valve implantation in uveitic glaucoma versus open-angle glaucoma patients. Can J Ophthalmol 43:462–467CrossRef Rachmiel R, Trope GE, Buys YM, Flanagan JG, Chipman ML (2008) Ahmed glaucoma valve implantation in uveitic glaucoma versus open-angle glaucoma patients. Can J Ophthalmol 43:462–467CrossRef
21.
Zurück zum Zitat Krishna R, Godfrey DG, Budenz DL, Escalona-Camaano E, Gedde SJ, Greenfield DS, Feuer W, Scott IU (2001) Intermediate-term outcomes of 350-mm(2) Baerveldt glaucoma implants. Ophthalmology 108:621–626CrossRef Krishna R, Godfrey DG, Budenz DL, Escalona-Camaano E, Gedde SJ, Greenfield DS, Feuer W, Scott IU (2001) Intermediate-term outcomes of 350-mm(2) Baerveldt glaucoma implants. Ophthalmology 108:621–626CrossRef
22.
Zurück zum Zitat Ritch R (1996) Chapter 55. In: Ritch R, Shields MB, Krupin T (eds) The glaucomas, 2nd edn. Mosby, St Louis, p 1178 Ritch R (1996) Chapter 55. In: Ritch R, Shields MB, Krupin T (eds) The glaucomas, 2nd edn. Mosby, St Louis, p 1178
23.
Zurück zum Zitat Gedde SJ, Feuer WJ, Shi W, Lim KS, Barton K, Goyal S, Ahmed IIK, Brandt J; Primary Tube Versus Trabeculectomy Study Group (2018) Treatment outcomes in the primary tube versus trabeculectomy study after 1 year of follow-up. Ophthalmology 125:650–663CrossRef Gedde SJ, Feuer WJ, Shi W, Lim KS, Barton K, Goyal S, Ahmed IIK, Brandt J; Primary Tube Versus Trabeculectomy Study Group (2018) Treatment outcomes in the primary tube versus trabeculectomy study after 1 year of follow-up. Ophthalmology 125:650–663CrossRef
24.
Zurück zum Zitat Bettis DI, Morshedi RG, Chaya C, Goldsmith J, Crandall A, Zabriskie N (2015) Trabeculectomy with mitomycin C or ahmed valve implantation in eyes with uveitic glaucoma. J Glaucoma 24:591–599CrossRef Bettis DI, Morshedi RG, Chaya C, Goldsmith J, Crandall A, Zabriskie N (2015) Trabeculectomy with mitomycin C or ahmed valve implantation in eyes with uveitic glaucoma. J Glaucoma 24:591–599CrossRef
25.
Zurück zum Zitat Kwon HJ, Kong YXG, Tao LW, Lim LL, Martin KR, Green C, Ruddle J, Crowston JG (2017) Surgical outcomes of trabeculectomy and glaucoma drainage implant for uveitic glaucoma and relationship with uveitis activity. Clin Exp Ophthalmol 45:472–480CrossRef Kwon HJ, Kong YXG, Tao LW, Lim LL, Martin KR, Green C, Ruddle J, Crowston JG (2017) Surgical outcomes of trabeculectomy and glaucoma drainage implant for uveitic glaucoma and relationship with uveitis activity. Clin Exp Ophthalmol 45:472–480CrossRef
26.
Zurück zum Zitat Broadway DC, Chang LP (2001) Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma 10:237–249CrossRef Broadway DC, Chang LP (2001) Trabeculectomy, risk factors for failure and the preoperative state of the conjunctiva. J Glaucoma 10:237–249CrossRef
27.
Zurück zum Zitat Hamanaka T, Takei A, Takemura T, Oritsu M (2002) Pathological study of cases with secondary open-angle glaucoma due to sarcoidosis. Am J Ophthalmol 134:17–26CrossRef Hamanaka T, Takei A, Takemura T, Oritsu M (2002) Pathological study of cases with secondary open-angle glaucoma due to sarcoidosis. Am J Ophthalmol 134:17–26CrossRef
28.
Zurück zum Zitat Hayashi S, Hamanaka T, Takemura T (2012) Pathological study of secondary glaucoma due to congenital syphilis-a new theory of vasculitis in the Schlemm’s canal. J Clin Exp Ophthalmol 3:249CrossRef Hayashi S, Hamanaka T, Takemura T (2012) Pathological study of secondary glaucoma due to congenital syphilis-a new theory of vasculitis in the Schlemm’s canal. J Clin Exp Ophthalmol 3:249CrossRef
29.
Zurück zum Zitat Su CC, Hu FR, Wang TH, Huang JY, Yeh PT, Lin CP, Wang IJ (2014) Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy. Am J Ophthalmol 158:1024–1031CrossRef Su CC, Hu FR, Wang TH, Huang JY, Yeh PT, Lin CP, Wang IJ (2014) Clinical outcomes in cytomegalovirus-positive Posner-Schlossman syndrome patients treated with topical ganciclovir therapy. Am J Ophthalmol 158:1024–1031CrossRef
30.
Zurück zum Zitat Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, Kuwayama Y, Mishima HK, Shimizu H, Tomita G, Inoue Y, Kitazawa Y; Tajimi Study Group, Japan Glaucoma Society (2004) The prevalence of primary open-angle glaucoma in Japanese: the Tajimi study. Ophthalmology 111:1641–1648 Iwase A, Suzuki Y, Araie M, Yamamoto T, Abe H, Shirato S, Kuwayama Y, Mishima HK, Shimizu H, Tomita G, Inoue Y, Kitazawa Y; Tajimi Study Group, Japan Glaucoma Society (2004) The prevalence of primary open-angle glaucoma in Japanese: the Tajimi study. Ophthalmology 111:1641–1648
31.
Zurück zum Zitat Kawamorita S, Hamanaka T, Sakurai T (2014) The early postoperative complications in two different tube ligation methods in Baerveldt implant surgery. J Curr Glaucoma Pract 8:96–100CrossRef Kawamorita S, Hamanaka T, Sakurai T (2014) The early postoperative complications in two different tube ligation methods in Baerveldt implant surgery. J Curr Glaucoma Pract 8:96–100CrossRef
32.
Zurück zum Zitat Hamanaka T, Otora K, Ono K, Ishida N (2014) Long-term results of non-valved Glaucoma drainage implant surgery and glaucoma drainage implant combined with trabeculectomy. Indian J Ophthalmol 62:911–916CrossRef Hamanaka T, Otora K, Ono K, Ishida N (2014) Long-term results of non-valved Glaucoma drainage implant surgery and glaucoma drainage implant combined with trabeculectomy. Indian J Ophthalmol 62:911–916CrossRef
Metadaten
Titel
Evaluation of the outcome of long-tube shunt implant surgery in uveitic glaucoma patients by analyzing the background of uveitis
verfasst von
Satoshi Watanabe
Teruhiko Hamanaka
Tetsuro Sakurai
Kanae Kobayashi
Nobuo Ishida
Nobuyuki Ebihara
Publikationsdatum
14.10.2020
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 2/2021
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-020-01601-3

Weitere Artikel der Ausgabe 2/2021

International Ophthalmology 2/2021 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.